Abstract | BACKGROUND: OBJECTIVE: METHODS: In a double-blind, placebo-controlled trial, 16 patients, from 918 who were screened, were randomized to the experimental group (EG, dexamphetamine + physiotherapy) or control group (CG, placebo + physiotherapy). Both groups received multidisciplinary inpatient rehabilitation. Dexamphetamine (10 mg oral) or placebo was administered 2 days per week before physiotherapy. ADL and motor function were measured using the Chedoke-McMaster Stroke Assessment (CMSA) twice during baseline, every week during the 5-week treatment period, and at follow-up 1 week, 6 months, and 12 months after intervention. RESULTS: The majority of ineligible patients had too little paresis, were on anticoagulants, or had a stroke >60 days prior to entry. Participants (EG, n = 7, age 70.3 ± 10 years, 5 women, 37.9 ± 9 days after stroke; CG, n = 9, age 65.2 ± 17 years, 3 women, 40.3 ± 9 days after stroke) did not differ at baseline except for the leg subscale. Analysis of variance from baseline to 1 week follow-up revealed significant improvements in favor of EG for subscales ADL (P = .023) and arm function (P = .020) at end of treatment. No adverse events were detected. CONCLUSION: In this small trial that was based on prior positive trials, significant gains in ADL and arm function suggest that the dose and timing of dexamphetamine can augment physiotherapy. Effect size calculation suggests inclusion of at least 25 patients per group in future studies.
|
Authors | Corina Schuster, Gerd Maunz, Karin Lutz, Udo Kischka, Rolf Sturzenegger, Thierry Ettlin |
Journal | Neurorehabilitation and neural repair
(Neurorehabil Neural Repair)
Vol. 25
Issue 8
Pg. 749-55
(Oct 2011)
ISSN: 1552-6844 [Electronic] United States |
PMID | 21712481
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Central Nervous System Stimulants
- Dextroamphetamine
|
Topics |
- Activities of Daily Living
- Aged
- Aged, 80 and over
- Analysis of Variance
- Central Nervous System Stimulants
(therapeutic use)
- Dextroamphetamine
(therapeutic use)
- Double-Blind Method
- Female
- Humans
- Longitudinal Studies
- Male
- Middle Aged
- Physical Therapy Modalities
- Pilot Projects
- Recovery of Function
(drug effects, physiology)
- Stroke
(drug therapy)
- Stroke Rehabilitation
- Time Factors
- Treatment Outcome
- Upper Extremity
(physiology)
|